FINANCIAL INFORMATION

Independency and transparency

Principle of non interference of any funder (public or private) or sponsor in GAMIAN-Europe’s activities
Subscription of EFPIA code of conduct (laid down by statute)

Principle of multi funding: GAMIAN-Europe is not dependent of an unique funder, and it’s activities will never be endangered by the threat of a funder to quit.

Democratic decision making on general policy
•    Yearly General Assembly
•    No financial barrier for full members to attend tehj meetings of the General Assembly
•    Yearly open discussion on activity report of the past year and planning for the coming year.

Financial transparency
•    Yearly financial report, by professional, independent accountant.
•    Audit report by professional auditor presented by the treasurer at annual general assembly.
•    Publication of all financial reports (income and expenses) and balance on website.
•    Full financial report publicly available at commercial court of Brussels

_______________________________________________________

2016-2017

OPERATING INCOME financial year 2016/2017: 215 920,16€

GRANTS RECEIVED IN 2016  (calendar year)

Industry related income

Janssen: 40.000 € (= 18,52 %)

Lundbeck: 55.050 € (= 25,50 %)

TEVA: 32.812,07 € ( = 15,20 %)

Pfizer: 20.000 € (= 9,26 %)

Shire: 4.900 € ( = 2,27 %)

Total Industry related income: 152.762,07€

Non-industry related income

ECNP: 8.630 € ( = 3,99 %) 

European Commission (Research project) : 42.184,08€  ( = 19,54 %)

GAMIAN-Europe membership: 4.290€ (= 1,98 %)

European Brain Council (IG meeting co-sponsorship): 2.362€ (= 1,1 %)

Fees paid to GAMIAN-Europe for participating at conferences : 5692.01€ (= 2,64 %)

Total non-industry related income: 63.158,09€

Total: 215.920,16€

Total industry funding  = 70%
Total Non industry funding = 30%
Highest industry grant:  =  25,50 %

Download

Audit Report 2017

Financial Statement 2016